Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine vs Dexmedetomidine in Pelviabdominal Cancer Surgery
NCT04148599Phase 3Completed
- Start
- Jan 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine, dexmedetomidine in Surgical stress response, postoperative pain. Started Jan 2018; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrinedexmedetomidine
03
Conditions
Surgical stress responsepostoperative pain
Beyond the preview
Go deeper on NCT04148599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04148599.